191:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
An overview of glaucoma:@0.076190:0.099847:0.497508:0.099847:0.497508:0.063183:0.076190:0.063183:0.024862:0.020159:0.009407:0.021503:0.018815:0.021503:0.010751:0.018815:0.008063:0.021503:0.026878:0.009407:0.021503:0.009407:0.009407:0.022175:0.008063:0.022175:0.020159:0.021503:0.021503:0.031582:0.022175
H Abrahamse-Pillay:@0.076190:0.169924:0.236788:0.169924:0.236788:0.151592:0.076190:0.151592:0.011423:0.004704:0.012431:0.011087:0.005376:0.011087:0.010079:0.011087:0.015791:0.007392:0.010751:0.007056:0.009407:0.004032:0.004032:0.004032:0.011087:0.009743
MBChB (UCT), FC Ophth (sA), MMed Ophth (Wits):@0.076190:0.182359:0.397480:0.182359:0.397480:0.168330:0.076190:0.168330:0.012351:0.007714:0.010926:0.008198:0.007714:0.003723:0.004959:0.008803:0.010926:0.005725:0.004959:0.003723:0.003723:0.006518:0.010926:0.003723:0.011679:0.009165:0.008198:0.004556:0.008198:0.003723:0.004959:0.006693:0.009945:0.004959:0.003723:0.003723:0.012351:0.012351:0.008735:0.009206:0.003723:0.011679:0.009165:0.008198:0.004556:0.008198:0.003723:0.004959:0.012902:0.002688:0.004556:0.005214:0.004959
Specialist Ophthalmologist, Division of Ophthalmology,:@0.076190:0.200709:0.430446:0.200709:0.430446:0.186680:0.076190:0.186680:0.006693:0.009165:0.008735:0.008695:0.002688:0.009179:0.002688:0.002688:0.005214:0.004556:0.003723:0.011679:0.009165:0.008198:0.004556:0.008198:0.009179:0.002688:0.012606:0.008803:0.002688:0.008803:0.009045:0.002688:0.005214:0.004556:0.003723:0.003723:0.009999:0.002688:0.007445:0.002688:0.005214:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.011679:0.009165:0.008198:0.004556:0.008198:0.009179:0.002688:0.012606:0.008803:0.002688:0.008803:0.009045:0.007203:0.003723
Stellenbosch University, Stellenbosch:@0.076190:0.213927:0.311671:0.213927:0.311671:0.199898:0.076190:0.199898:0.006693:0.004556:0.008735:0.002688:0.002688:0.008735:0.008198:0.009165:0.008803:0.005214:0.008695:0.008198:0.003723:0.008803:0.008198:0.002688:0.007445:0.008735:0.004045:0.005214:0.002688:0.004556:0.007203:0.003723:0.003723:0.006693:0.004556:0.008735:0.002688:0.002688:0.008735:0.008198:0.009165:0.008803:0.005214:0.008695:0.008198
Glaucoma is a group  of  pathological  disorders that :@0.076190:0.244231:0.485130:0.244231:0.485130:0.228449:0.076190:0.228449:0.013184:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.008376:0.003024:0.005866:0.008376:0.010326:0.008376:0.010175:0.004551:0.009903:0.009192:0.010311:0.004188:0.004173:0.009903:0.004747:0.004188:0.004173:0.010311:0.010326:0.005125:0.009223:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.004188:0.004173:0.010357:0.003024:0.005866:0.009903:0.004551:0.010357:0.009827:0.004551:0.005866:0.008376:0.005125:0.009223:0.010326:0.005125:0.004188
causes a progressive, often bilateral, optic neuropathy :@0.076190:0.258732:0.485145:0.258732:0.485145:0.242950:0.076190:0.242950:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.005110:0.010326:0.005110:0.010311:0.004551:0.009903:0.010175:0.004536:0.009827:0.005866:0.005866:0.003024:0.008376:0.009827:0.004188:0.005110:0.009903:0.004747:0.005125:0.009827:0.009223:0.005095:0.010311:0.003024:0.003024:0.010326:0.005125:0.009827:0.004551:0.010326:0.003024:0.004188:0.005110:0.009903:0.010311:0.005125:0.003024:0.009782:0.005110:0.009223:0.009827:0.009192:0.004551:0.009903:0.010311:0.010326:0.005125:0.009223:0.008104:0.004188
that is associated with characteristic structural damage :@0.076190:0.273233:0.485145:0.273233:0.485145:0.257451:0.076190:0.257451:0.005125:0.009223:0.010326:0.005125:0.003916:0.003024:0.005866:0.003916:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.003916:0.012564:0.003024:0.005125:0.009223:0.003916:0.009782:0.009223:0.010326:0.004551:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.005866:0.005125:0.003024:0.009782:0.003916:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.009192:0.004551:0.010326:0.003024:0.003916:0.010357:0.010326:0.014182:0.010326:0.010175:0.009827:0.004188
of the optic nerve and has associated visual dysfunc-:@0.076190:0.287735:0.480942:0.287735:0.480942:0.271952:0.076190:0.271952:0.009903:0.004747:0.006017:0.005125:0.009223:0.009827:0.006017:0.009903:0.010311:0.005125:0.003024:0.009782:0.006017:0.009223:0.009827:0.004551:0.008376:0.009827:0.006017:0.010326:0.009223:0.010357:0.006017:0.009223:0.010326:0.005866:0.006017:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.006017:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.006032:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005020
tion, including visual field loss.:@0.076190:0.302236:0.293330:0.302236:0.293330:0.286453:0.076190:0.286453:0.005125:0.003024:0.009903:0.009223:0.004188:0.004853:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.004853:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.004868:0.003681:0.003681:0.009827:0.003024:0.010357:0.004853:0.003024:0.009903:0.005866:0.005866:0.004188
1:@0.293330:0.296957:0.298188:0.296957:0.298188:0.287804:0.293330:0.287804:0.004858
 Raised intra-ocular pres-:@0.298189:0.302256:0.480948:0.302256:0.480948:0.286473:0.298189:0.286473:0.004853:0.009177:0.010326:0.003024:0.005866:0.009827:0.010357:0.004853:0.003024:0.009223:0.005125:0.004551:0.010326:0.005020:0.009903:0.009782:0.009192:0.003024:0.010326:0.004551:0.004853:0.010311:0.004551:0.009827:0.005866:0.005020
sure is one of the main risk factors, but its absence does :@0.076197:0.316757:0.485136:0.316757:0.485136:0.300975:0.076197:0.300975:0.005866:0.009192:0.004551:0.009827:0.004233:0.003024:0.005866:0.004248:0.009903:0.009223:0.009827:0.004233:0.009903:0.004747:0.004233:0.005125:0.009223:0.009827:0.004233:0.014182:0.010326:0.003024:0.009223:0.004248:0.004551:0.003024:0.005866:0.007590:0.004233:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.004233:0.010311:0.009192:0.005125:0.004233:0.003024:0.005125:0.005866:0.004248:0.010326:0.010311:0.005866:0.009827:0.009223:0.009782:0.009827:0.004233:0.010357:0.009903:0.009827:0.005866:0.004188
not exclude disease. Functional damage is also taken :@0.076197:0.331258:0.485136:0.331258:0.485136:0.315476:0.076197:0.315476:0.009223:0.009903:0.005125:0.005775:0.009827:0.007257:0.009782:0.003024:0.009192:0.010357:0.009827:0.005791:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.005791:0.007333:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.005775:0.010357:0.010326:0.014182:0.010326:0.010175:0.009827:0.005791:0.003024:0.005866:0.005791:0.010326:0.003024:0.005866:0.009903:0.005791:0.005125:0.010326:0.007590:0.009827:0.009223:0.004188
into consideration, but again does not form part of the :@0.076197:0.345759:0.485136:0.345759:0.485136:0.329977:0.076197:0.329977:0.003024:0.009223:0.005125:0.009903:0.004747:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004747:0.010311:0.009192:0.005125:0.004747:0.010326:0.010175:0.010326:0.003024:0.009223:0.004747:0.010357:0.009903:0.009827:0.005866:0.004747:0.009223:0.009903:0.005125:0.004747:0.004747:0.009903:0.004551:0.014182:0.004747:0.010311:0.010326:0.004551:0.005125:0.004747:0.009903:0.004747:0.004747:0.005125:0.009223:0.009827:0.004188
definition of glaucoma. Glaucoma can be congenital, :@0.076197:0.360260:0.485167:0.360260:0.485167:0.344478:0.076197:0.344478:0.010357:0.009827:0.003681:0.003681:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.004793:0.009903:0.004747:0.004793:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.004793:0.013184:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004793:0.009782:0.010326:0.009223:0.004793:0.010311:0.009827:0.004793:0.009782:0.009903:0.009223:0.010175:0.009827:0.009223:0.003024:0.005125:0.010326:0.003024:0.004188:0.004188
primary or acquired and can have ocular or systemic :@0.076197:0.374762:0.485151:0.374762:0.485151:0.358979:0.076197:0.358979:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.005987:0.009903:0.004551:0.005987:0.010326:0.009782:0.010311:0.009192:0.003024:0.004551:0.009827:0.010357:0.005987:0.010326:0.009223:0.010357:0.005987:0.009782:0.010326:0.009223:0.005987:0.009223:0.010326:0.008376:0.009827:0.005987:0.009903:0.009782:0.009192:0.003024:0.010326:0.004551:0.005987:0.009903:0.004551:0.005987:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.003024:0.009782:0.004188
associations (see Figure 1).:@0.076197:0.389263:0.270340:0.389263:0.270340:0.373480:0.076197:0.373480:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.005579:0.005866:0.009827:0.009827:0.004188:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.004188:0.008376:0.005579:0.004188
ClAssifiCAtiOn Of GlAuCOmA :@0.076190:0.422547:0.370373:0.422547:0.370373:0.402382:0.076190:0.402382:0.014413:0.008131:0.013674:0.009609:0.009609:0.005174:0.008870:0.005174:0.014413:0.013674:0.007761:0.005174:0.015522:0.013674:0.005174:0.015522:0.008870:0.005174:0.015522:0.008131:0.013674:0.011826:0.014413:0.015522:0.016631:0.013674:0.005174
(GOniOsCOPiCAlly):@0.076190:0.439621:0.266522:0.439621:0.266522:0.419456:0.076190:0.419456:0.007022:0.015522:0.015522:0.013674:0.005174:0.015522:0.009609:0.014413:0.015522:0.010348:0.005174:0.014413:0.013674:0.008131:0.008131:0.011457:0.007022
2,3:@0.266483:0.433142:0.281487:0.433142:0.281487:0.421447:0.266483:0.421447:0.006002:0.003001:0.006002
There  are  different  ways to  classify glaucoma  based :@0.076190:0.455903:0.485130:0.455903:0.485130:0.440120:0.076190:0.440120:0.006441:0.009223:0.009827:0.004551:0.009827:0.004188:0.003311:0.010326:0.004551:0.009827:0.004188:0.003311:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.009827:0.009223:0.005125:0.004188:0.003311:0.012564:0.010326:0.008104:0.005866:0.007514:0.005125:0.009903:0.004188:0.003311:0.009782:0.003024:0.010326:0.005866:0.005866:0.003024:0.004747:0.008104:0.007514:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.003311:0.010311:0.010326:0.005866:0.009827:0.010357:0.004188
on the anatomical, gonioscopic-angle-evaluation, bio-:@0.076190:0.470404:0.480942:0.470404:0.480942:0.454621:0.076190:0.454621:0.009903:0.009223:0.004430:0.005125:0.009223:0.009827:0.004430:0.010326:0.009223:0.010326:0.005125:0.009903:0.014182:0.003024:0.009782:0.010326:0.003024:0.004188:0.004430:0.010175:0.009903:0.009223:0.003024:0.009903:0.005866:0.009782:0.009903:0.010311:0.003024:0.009782:0.005020:0.010326:0.009223:0.010175:0.003024:0.009827:0.005020:0.009827:0.008376:0.010326:0.003024:0.009192:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004430:0.010311:0.003024:0.009903:0.005020
chemical,  molecular  and  genetic  views. Each  has  its :@0.076190:0.484905:0.485115:0.484905:0.485115:0.469122:0.076190:0.469122:0.009782:0.009223:0.009827:0.014182:0.003024:0.009782:0.010326:0.003024:0.004188:0.004188:0.002948:0.014182:0.009903:0.003024:0.009827:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.002948:0.010326:0.009223:0.010357:0.004188:0.002948:0.010175:0.009827:0.009223:0.009827:0.005125:0.003024:0.009782:0.004188:0.002948:0.008376:0.003024:0.009827:0.012564:0.005866:0.004188:0.007151:0.008104:0.010326:0.009782:0.009223:0.004188:0.002948:0.009223:0.010326:0.005866:0.004188:0.002948:0.003024:0.005125:0.005866:0.004188
benefits.  Here,  the  gonioscopic  classification  is  used. :@0.076190:0.499406:0.485145:0.499406:0.485145:0.483623:0.076190:0.483623:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005866:0.004188:0.004188:0.003855:0.010326:0.009827:0.004551:0.009827:0.004188:0.004188:0.003855:0.005125:0.009223:0.009827:0.004188:0.003855:0.010175:0.009903:0.009223:0.003024:0.009903:0.005866:0.009782:0.009903:0.010311:0.003024:0.009782:0.004188:0.003855:0.009782:0.003024:0.010326:0.005866:0.005866:0.003024:0.003681:0.003681:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003870:0.003024:0.005866:0.004188:0.003870:0.009192:0.005866:0.009827:0.010357:0.004188:0.004188
Employing the traditional method of defining whether :@0.076190:0.513907:0.485160:0.513907:0.485160:0.498125:0.076190:0.498125:0.008104:0.014182:0.010311:0.003024:0.009903:0.008104:0.003024:0.009223:0.010175:0.006305:0.005125:0.009223:0.009827:0.006290:0.005125:0.004551:0.010326:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.006290:0.014182:0.009827:0.005125:0.009223:0.009903:0.010357:0.006290:0.009903:0.004747:0.006290:0.010357:0.009827:0.003681:0.003681:0.009223:0.003024:0.009223:0.010175:0.006290:0.012564:0.009223:0.009827:0.005125:0.009223:0.009827:0.004551:0.004188
the angle is open or closed has implications for the dif-:@0.076190:0.528408:0.480927:0.528408:0.480927:0.512626:0.076190:0.512626:0.005125:0.009223:0.009827:0.004778:0.010326:0.009223:0.010175:0.003024:0.009827:0.004793:0.003024:0.005866:0.004793:0.009903:0.010311:0.009827:0.009223:0.004793:0.009903:0.004551:0.004778:0.009782:0.003024:0.009903:0.005866:0.009827:0.010357:0.004793:0.009223:0.010326:0.005866:0.004793:0.003024:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004793:0.004747:0.009903:0.004551:0.004778:0.005125:0.009223:0.009827:0.004778:0.010357:0.003024:0.004747:0.005020
ferent treatment options available. :@0.076190:0.542909:0.335663:0.542909:0.335663:0.527127:0.076190:0.527127:0.004747:0.009827:0.004551:0.009827:0.009223:0.005125:0.004188:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.009903:0.010311:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188:0.004188
The three primary alphanumeric systems that are cur-:@0.090478:0.557410:0.480927:0.557410:0.480927:0.541628:0.090478:0.541628:0.006441:0.009223:0.009827:0.004354:0.005125:0.009223:0.004551:0.009812:0.009827:0.004354:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.004354:0.010326:0.003024:0.010311:0.009223:0.010326:0.009223:0.009192:0.014182:0.009827:0.004551:0.003024:0.009782:0.004354:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.005866:0.004369:0.005125:0.009223:0.010326:0.005125:0.004354:0.010326:0.004551:0.009827:0.004354:0.009782:0.009192:0.004551:0.005020
rently used for grading the angle are those of scheie, :@0.076190:0.571911:0.485160:0.571911:0.485160:0.556129:0.076190:0.556129:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.005912:0.009192:0.005866:0.009827:0.010357:0.005912:0.004747:0.009903:0.004551:0.005912:0.010175:0.004551:0.010326:0.010357:0.003024:0.009223:0.010175:0.005912:0.005125:0.009223:0.009827:0.005912:0.010326:0.009223:0.010175:0.003024:0.009827:0.005912:0.010326:0.004551:0.009827:0.005912:0.005125:0.009223:0.009903:0.005866:0.009827:0.005912:0.009903:0.004747:0.005912:0.007529:0.009782:0.009223:0.009827:0.003024:0.009827:0.004188:0.004188
Shaffer,  and  Spaeth.  The  Shaffer  classification  is  the :@0.076190:0.586413:0.485130:0.586413:0.485130:0.570630:0.076190:0.570630:0.007529:0.009223:0.010326:0.004747:0.004747:0.009827:0.004551:0.004188:0.004188:0.004521:0.010326:0.009223:0.010357:0.004188:0.004536:0.007529:0.010311:0.010326:0.009827:0.005125:0.009223:0.004188:0.004188:0.004536:0.006441:0.009223:0.009827:0.004188:0.004521:0.007529:0.009223:0.010326:0.004747:0.004747:0.009827:0.004551:0.004188:0.004536:0.009782:0.003024:0.010326:0.005866:0.005866:0.003024:0.003681:0.003681:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004536:0.003024:0.005866:0.004188:0.004536:0.005125:0.009223:0.009827:0.004188
most commonly used. The Scheie classification uses Ro:@0.076190:0.600914:0.475923:0.600914:0.475923:0.585131:0.076190:0.585131:0.014182:0.009903:0.005866:0.005125:0.004248:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.003024:0.008104:0.004248:0.009192:0.005866:0.009827:0.010357:0.004188:0.004248:0.006441:0.009223:0.009827:0.004248:0.007529:0.009782:0.009223:0.009827:0.003024:0.009827:0.004248:0.009782:0.003024:0.010326:0.005866:0.005866:0.003024:0.003681:0.003681:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004264:0.009192:0.005866:0.009827:0.005866:0.004248:0.009177:0.009903
-:@0.475923:0.600914:0.480942:0.600914:0.480942:0.585131:0.475923:0.585131:0.005020
man numerals, and the  angles are  graded inversely. :@0.076190:0.615415:0.485145:0.615415:0.485145:0.599632:0.076190:0.599632:0.014182:0.010326:0.009223:0.007408:0.009223:0.009192:0.014182:0.009827:0.004551:0.010326:0.003024:0.005866:0.004188:0.007408:0.010326:0.009223:0.010357:0.007408:0.005125:0.009223:0.009827:0.004188:0.003205:0.010326:0.009223:0.010175:0.003024:0.009827:0.005866:0.007408:0.010326:0.004551:0.009827:0.004188:0.003205:0.010175:0.004551:0.010326:0.010357:0.009827:0.010357:0.007408:0.003024:0.009223:0.008376:0.009827:0.004551:0.005866:0.009827:0.003024:0.008104:0.004188:0.004188
The Spaeth classification uses all the available informa:@0.076190:0.629916:0.475923:0.629916:0.475923:0.614133:0.076190:0.614133:0.006441:0.009223:0.009827:0.004762:0.007529:0.010311:0.010326:0.009827:0.005125:0.009223:0.004778:0.009782:0.003024:0.010326:0.005866:0.005866:0.003024:0.003681:0.003681:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004778:0.009192:0.005866:0.009827:0.005866:0.004778:0.010326:0.003024:0.003024:0.004778:0.005125:0.009223:0.009827:0.004778:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004793:0.003024:0.009223:0.004747:0.009903:0.004551:0.014182:0.010326
-:@0.475923:0.629916:0.480942:0.629916:0.480942:0.614133:0.475923:0.614133:0.005020
tion to offer a more comprehensive classification.:@0.076190:0.644417:0.436931:0.644417:0.436931:0.628634:0.076190:0.628634:0.005125:0.003024:0.009903:0.009223:0.004188:0.005125:0.009903:0.004188:0.009903:0.004747:0.004747:0.009827:0.004551:0.004188:0.010326:0.004188:0.014182:0.009903:0.004551:0.009827:0.004188:0.009782:0.009903:0.014182:0.010311:0.004551:0.009827:0.009223:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.004188:0.009782:0.003024:0.010326:0.005866:0.005866:0.003024:0.003681:0.003681:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
shaffer :@0.076190:0.676060:0.136331:0.676060:0.136331:0.657729:0.076190:0.657729:0.008735:0.010079:0.011087:0.004704:0.004704:0.010751:0.005376:0.004704
  Grade 4 (35-450): ciliary body visible:@0.090476:0.692738:0.363798:0.692738:0.363798:0.676956:0.090476:0.676956:0.004188:0.005337:0.013184:0.004551:0.010326:0.010357:0.009827:0.004188:0.008376:0.004188:0.005579:0.008376:0.008376:0.005020:0.008391:0.008376:0.008376:0.005579:0.004188:0.004188:0.009782:0.003024:0.003024:0.003024:0.010326:0.004551:0.008104:0.004188:0.010311:0.009903:0.010372:0.008104:0.004188:0.008376:0.003024:0.005866:0.003024:0.010311:0.003024:0.009827
  Grade 3 (25-350): scleral spur visible:@0.090476:0.707239:0.359610:0.707239:0.359610:0.691457:0.090476:0.691457:0.004188:0.005337:0.013184:0.004551:0.010326:0.010357:0.009827:0.004188:0.008376:0.004188:0.005579:0.008376:0.008376:0.005020:0.008391:0.008376:0.008376:0.005579:0.004188:0.004188:0.005866:0.009782:0.003024:0.009827:0.004551:0.010326:0.003024:0.004188:0.005866:0.010311:0.009207:0.004551:0.004188:0.008376:0.003024:0.005866:0.003024:0.010311:0.003024:0.009827
  Grade 2 (200): trabecular meshwork visible:@0.090476:0.721740:0.412209:0.721740:0.412209:0.705958:0.090476:0.705958:0.004188:0.005337:0.013184:0.004551:0.010326:0.010357:0.009827:0.004188:0.008376:0.004188:0.005579:0.008376:0.008376:0.008376:0.005594:0.004188:0.004188:0.005125:0.004551:0.010326:0.010311:0.009827:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.014182:0.009812:0.005866:0.009223:0.012564:0.009903:0.004551:0.007590:0.004188:0.008376:0.003024:0.005866:0.003024:0.010311:0.003024:0.009827
  Grade 1 (100): schwalbe’s line visible:@0.090476:0.736241:0.370360:0.736241:0.370360:0.720459:0.090476:0.720459:0.004188:0.005337:0.013184:0.004551:0.010326:0.010357:0.009827:0.004188:0.008376:0.004188:0.005579:0.008376:0.008376:0.008376:0.005594:0.004188:0.004188:0.007529:0.009782:0.009223:0.012564:0.010326:0.003024:0.010311:0.009827:0.005307:0.005866:0.004188:0.003024:0.003024:0.009223:0.009827:0.004188:0.008376:0.003024:0.005866:0.003024:0.010311:0.003024:0.009827
  Grade 0 (00): iridocorneal touch:@0.090476:0.750743:0.336176:0.750743:0.336176:0.734960:0.090476:0.734960:0.004188:0.005337:0.013184:0.004551:0.010326:0.010357:0.009827:0.004188:0.008376:0.004188:0.005579:0.008376:0.008376:0.005579:0.004188:0.004188:0.003024:0.004551:0.003024:0.010357:0.009903:0.009782:0.009903:0.004551:0.009223:0.009827:0.010326:0.003024:0.004188:0.005125:0.009888:0.009192:0.009782:0.009223
PreVAlenCe :@0.076190:0.784016:0.194085:0.784016:0.194085:0.763852:0.076190:0.763852:0.010348:0.010718:0.009609:0.012935:0.013674:0.008131:0.009609:0.013674:0.014413:0.009609:0.005174
Glaucoma is the second leading cause of blindness :@0.076190:0.800301:0.485145:0.800301:0.485145:0.784518:0.076190:0.784518:0.013184:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.007786:0.003024:0.005866:0.007786:0.005125:0.009223:0.009827:0.007786:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.007786:0.003024:0.009827:0.010326:0.010357:0.003024:0.009223:0.010175:0.007786:0.009782:0.010326:0.009192:0.005866:0.009827:0.007786:0.009903:0.004747:0.007786:0.010311:0.003024:0.003024:0.009223:0.010357:0.009223:0.009827:0.005866:0.005866:0.004188
worldwide, accounting  for  15% of blindness in Africa :@0.076190:0.814802:0.485130:0.814802:0.485130:0.799019:0.076190:0.799019:0.012564:0.009903:0.004551:0.003024:0.010357:0.012564:0.003024:0.010357:0.009827:0.004188:0.007680:0.010326:0.009782:0.009782:0.009903:0.009192:0.009223:0.005125:0.003024:0.009223:0.010175:0.004188:0.003477:0.004747:0.009903:0.004551:0.004188:0.003477:0.008376:0.008376:0.011717:0.007680:0.009903:0.004747:0.007680:0.010311:0.003024:0.003024:0.009223:0.010357:0.009223:0.009827:0.005866:0.005866:0.007680:0.003024:0.009223:0.007680:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188
(8% of the 39 million blind population worldwide).  Ac-:@0.076190:0.829303:0.480951:0.829313:0.480951:0.813530:0.076190:0.813520:0.005579:0.008376:0.011717:0.005639:0.009903:0.004747:0.005624:0.005125:0.009223:0.009827:0.005624:0.008376:0.008376:0.005639:0.014182:0.003024:0.003024:0.003024:0.003024:0.009903:0.009223:0.005639:0.010311:0.003024:0.003024:0.009223:0.010357:0.005639:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005624:0.012564:0.009903:0.004551:0.003024:0.010357:0.012564:0.003024:0.010357:0.009827:0.005579:0.004188:0.004847:0.005624:0.011188:0.009782:-0.231745
4:@0.444477:0.824014:0.449335:0.824014:0.449335:0.814861:0.444477:0.814861:0.004858
cording  to studies conducted  in sub-saharan Africa, :@0.076184:0.843814:0.485124:0.843814:0.485124:0.828032:0.076184:0.828032:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.004188:0.003795:0.005125:0.009903:0.007998:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.007998:0.009782:0.009903:0.009223:0.010357:0.009192:0.009782:0.005125:0.009827:0.010357:0.004188:0.003795:0.003024:0.009223:0.007998:0.005866:0.009192:0.010311:0.005020:0.007529:0.010326:0.009223:0.010326:0.004551:0.010326:0.009223:0.007998:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188:0.004188
including  south Africa, the prevalence of all  types of :@0.076184:0.858315:0.485139:0.858315:0.485139:0.842533:0.076184:0.842533:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.004188:0.002661:0.007529:0.009903:0.009192:0.005125:0.009223:0.006849:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188:0.006849:0.005125:0.009223:0.009827:0.006849:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.006849:0.009903:0.004747:0.006849:0.010326:0.003024:0.003024:0.004188:0.002676:0.005125:0.008104:0.010311:0.009827:0.005866:0.006849:0.009903:0.004747:0.004188
glaucoma ranges from 4,5% to 5,3%. Open-angle glau-:@0.076184:0.872816:0.480951:0.872816:0.480951:0.857034:0.076184:0.857034:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004596:0.004551:0.010326:0.009223:0.010175:0.009827:0.005866:0.004581:0.004747:0.004551:0.009903:0.014182:0.004581:0.008376:0.004188:0.008376:0.011717:0.004596:0.005125:0.009903:0.004596:0.008376:0.004188:0.008376:0.011717:0.004188:0.004596:0.013138:0.010311:0.009827:0.009223:0.005020:0.010326:0.009223:0.010175:0.003024:0.009827:0.004596:0.010175:0.003024:0.010326:0.009192:0.005020
coma is six times more  prevalent than closed-angle :@0.076184:0.887317:0.485124:0.887317:0.485124:0.871535:0.076184:0.871535:0.009782:0.009903:0.014182:0.010326:0.008315:0.003024:0.005866:0.008315:0.005866:0.003024:0.007257:0.008315:0.005125:0.003024:0.014182:0.009827:0.005866:0.008315:0.014182:0.009903:0.004551:0.009827:0.004188:0.004112:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.005125:0.008315:0.005125:0.009223:0.010326:0.009223:0.008315:0.009782:0.003024:0.009903:0.005866:0.009827:0.010357:0.005020:0.010326:0.009223:0.010175:0.003024:0.009827:0.004188
glaucoma in the same population set, except in those :@0.076184:0.901819:0.485139:0.901819:0.485139:0.886036:0.076184:0.886036:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005201:0.003024:0.009223:0.005201:0.005125:0.009223:0.009827:0.005186:0.005866:0.010326:0.014182:0.009827:0.005201:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005201:0.005866:0.009827:0.005125:0.004188:0.005186:0.009827:0.007257:0.009782:0.009827:0.010311:0.005125:0.005186:0.003024:0.009223:0.005201:0.005125:0.009223:0.009903:0.005866:0.009827:0.004188
of mixed south East Asian and western European origins :@0.076184:0.916320:0.485139:0.916320:0.485139:0.900537:0.076184:0.900537:0.009903:0.004747:0.003916:0.014182:0.003024:0.007257:0.009827:0.010357:0.003931:0.007529:0.009903:0.009192:0.005125:0.009223:0.003916:0.008104:0.010326:0.005866:0.005125:0.003931:0.011188:0.005866:0.003024:0.010326:0.009223:0.003916:0.010326:0.009223:0.010357:0.003916:0.012564:0.009827:0.005866:0.005125:0.009827:0.004551:0.009223:0.003916:0.008104:0.009192:0.004551:0.009903:0.010311:0.009827:0.010326:0.009223:0.003916:0.009903:0.004551:0.003024:0.010175:0.003024:0.009223:0.005866:0.004188
who have an almost twofold presence of closed-angle :@0.076184:0.930821:0.485109:0.930821:0.485109:0.915038:0.076184:0.915038:0.012564:0.009223:0.009903:0.004490:0.009223:0.010326:0.008376:0.009827:0.004505:0.010326:0.009223:0.004505:0.010326:0.003024:0.014182:0.009903:0.005866:0.005125:0.004505:0.005125:0.012564:0.009903:0.004747:0.009903:0.003024:0.010357:0.004490:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.009782:0.009827:0.004490:0.009903:0.004747:0.004490:0.009782:0.003024:0.009903:0.005866:0.009827:0.010357:0.005020:0.010326:0.009223:0.010175:0.003024:0.009827:0.004188
glaucoma, compared to open-angle glaucoma.:@0.076184:0.945322:0.436259:0.945322:0.436259:0.929539:0.076184:0.929539:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.004188:0.009782:0.009903:0.014182:0.010311:0.010326:0.004551:0.009827:0.010357:0.004188:0.005125:0.009903:0.004188:0.009903:0.010311:0.009827:0.009223:0.005020:0.010326:0.009223:0.010175:0.003024:0.009827:0.004188:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188
The  proportion  of people who  are bilaterally  blind :@0.533323:0.168532:0.927991:0.168532:0.927991:0.152750:0.533323:0.152750:0.006441:0.009223:0.009827:0.004188:0.003991:0.010311:0.004551:0.009903:0.010311:0.009903:0.004551:0.005125:0.003024:0.009903:0.009223:0.004188:0.003991:0.009903:0.004747:0.008195:0.010311:0.009827:0.009903:0.010311:0.003024:0.009827:0.008195:0.012564:0.009223:0.009903:0.004188:0.003991:0.010326:0.004551:0.009827:0.008195:0.010311:0.003024:0.003024:0.010326:0.005125:0.009827:0.004551:0.010326:0.003024:0.003024:0.008104:0.004188:0.004022:0.010311:0.003024:0.003024:0.009223:0.010357:0.004188
from glaucoma ranged from 9,5% to 33%. Between 41% :@0.519036:0.183357:0.927976:0.183357:0.927976:0.167574:0.519036:0.167574:0.004747:0.004551:0.009903:0.014182:0.004082:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004097:0.004551:0.010326:0.009223:0.010175:0.009827:0.010357:0.004082:0.004747:0.004551:0.009903:0.014182:0.004082:0.008376:0.004188:0.008376:0.011717:0.004097:0.005125:0.009903:0.004097:0.008376:0.008376:0.011717:0.004188:0.004097:0.008678:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.004097:0.008376:0.008376:0.011717:0.004188
and 58% were blind in one eye. primary open-angled :@0.519036:0.198181:0.927991:0.198181:0.927991:0.182399:0.519036:0.182399:0.010326:0.009223:0.010357:0.006199:0.008376:0.008376:0.011717:0.006214:0.012564:0.009827:0.004551:0.009827:0.006199:0.010311:0.003024:0.003024:0.009223:0.010357:0.006214:0.003024:0.009223:0.006199:0.009903:0.009223:0.009827:0.006199:0.009827:0.008104:0.009827:0.004188:0.006214:0.008950:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.006199:0.009903:0.010311:0.009827:0.009223:0.005020:0.010326:0.009223:0.010175:0.003024:0.009827:0.010357:0.004188
glaucoma is the most prevalent form and is predicted :@0.519036:0.213006:0.927976:0.213006:0.927976:0.197223:0.519036:0.197223:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005473:0.003024:0.005866:0.005473:0.005125:0.009223:0.009827:0.005473:0.014182:0.009903:0.005866:0.005125:0.005473:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.005125:0.005473:0.004747:0.009903:0.004551:0.014182:0.005458:0.010326:0.009223:0.010357:0.005473:0.003024:0.005866:0.005473:0.010311:0.004551:0.009827:0.010357:0.003024:0.009782:0.005125:0.009827:0.010357:0.004188
to  affect  80 million people  worldwide  by 2020.   The :@0.519036:0.227830:0.927997:0.227883:0.927997:0.212100:0.519036:0.212047:0.005125:0.009903:0.004188:0.004203:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.004188:0.004203:0.008376:0.008376:0.008406:0.014182:0.003024:0.003024:0.003024:0.003024:0.009903:0.009223:0.008406:0.010311:0.009827:0.009903:0.010311:0.003024:0.009827:0.004188:0.004203:0.012564:0.009903:0.004551:0.003024:0.010357:0.012564:0.003024:0.010357:0.009827:0.004188:0.004203:0.010311:0.008104:0.008406:0.008376:0.008376:0.008376:0.008376:0.004188:0.004890:0.004188:0.004203:0.006441:0.009223:0.009827:0.107964
4:@0.885068:0.222584:0.889926:0.222584:0.889926:0.213430:0.885068:0.213430:0.004858
black populations of the Caribbean, Africa and the UsA :@0.519043:0.242707:0.927997:0.242707:0.927997:0.226925:0.519043:0.226925:0.010311:0.003024:0.010326:0.009782:0.007590:0.003508:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.003508:0.009903:0.004747:0.003492:0.005125:0.009223:0.009827:0.003492:0.012292:0.010326:0.004551:0.003024:0.010311:0.010311:0.009827:0.010326:0.009223:0.004188:0.003508:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.003492:0.010326:0.009223:0.010357:0.003508:0.005125:0.009223:0.009827:0.003492:0.009903:0.007529:0.011188:0.004188
have the highest prevalence of open-angle glaucoma. :@0.519043:0.257532:0.927982:0.257532:0.927982:0.241749:0.519043:0.241749:0.009223:0.010326:0.008376:0.009827:0.003780:0.005125:0.009223:0.009827:0.003780:0.009223:0.003024:0.010175:0.009223:0.009827:0.005866:0.005125:0.003780:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.003780:0.009903:0.004747:0.003780:0.009903:0.010311:0.009827:0.009223:0.005020:0.010326:0.009223:0.010175:0.003024:0.009827:0.003780:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.004188
Even within this group, there are differences in preva-:@0.519043:0.272356:0.923809:0.272356:0.923809:0.256573:0.519043:0.256573:0.008104:0.008376:0.009827:0.009223:0.006229:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.006229:0.005125:0.009223:0.003024:0.005866:0.006229:0.010175:0.004551:0.009903:0.009192:0.010311:0.004188:0.006214:0.005125:0.009223:0.009827:0.004551:0.009827:0.006214:0.010326:0.004551:0.009827:0.006229:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.009827:0.009223:0.009782:0.009827:0.005866:0.006229:0.003024:0.009223:0.006229:0.010311:0.004551:0.009827:0.008376:0.010326:0.005020
lence,  depending on  genetics, environmental  factors :@0.519043:0.287180:0.927997:0.287180:0.927997:0.271398:0.519043:0.271398:0.003024:0.009827:0.009223:0.009782:0.009827:0.004188:0.004188:0.002661:0.010357:0.009827:0.010311:0.009827:0.009223:0.010357:0.003024:0.009223:0.010175:0.006864:0.009903:0.009223:0.004188:0.002661:0.010175:0.009827:0.009223:0.009827:0.005125:0.003024:0.009782:0.005866:0.004188:0.006864:0.009827:0.009223:0.008376:0.003024:0.004551:0.009903:0.009223:0.014182:0.009827:0.009223:0.005125:0.010326:0.003024:0.004188:0.002661:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188
and socio-economic factors. Glaucoma has an ear-:@0.519043:0.302005:0.923779:0.302005:0.923779:0.286222:0.519043:0.286222:0.010326:0.009223:0.010357:0.007771:0.005866:0.009903:0.009782:0.003024:0.009903:0.005020:0.009827:0.009782:0.009903:0.009223:0.009903:0.014182:0.003024:0.009782:0.007771:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004173:0.007771:0.013184:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.007771:0.009223:0.010326:0.005866:0.007771:0.010326:0.009223:0.007771:0.009827:0.010326:0.004551:0.005020
lier onset in black populations with a more aggressive :@0.519043:0.316829:0.927967:0.316829:0.927967:0.301046:0.519043:0.301046:0.003024:0.003024:0.009827:0.004551:0.006017:0.009903:0.009223:0.005866:0.009827:0.005125:0.006017:0.003024:0.009223:0.006017:0.010311:0.003024:0.010326:0.009782:0.007590:0.006017:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.006017:0.012564:0.003024:0.005125:0.009223:0.006017:0.010326:0.006017:0.014182:0.009903:0.004551:0.009827:0.006017:0.010326:0.010175:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.008376:0.009827:0.004188
clinical course.  According  to  Dr John  salmon (Oxford :@0.519043:0.331653:0.927997:0.331653:0.927997:0.315871:0.519043:0.315871:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.006592:0.009782:0.009903:0.009192:0.004551:0.005866:0.009827:0.004188:0.004188:0.002389:0.011188:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.004188:0.002389:0.005125:0.009903:0.004188:0.002389:0.011249:0.004551:0.006592:0.007287:0.009903:0.009223:0.009223:0.004188:0.002389:0.007529:0.010326:0.003024:0.014182:0.009903:0.009223:0.006592:0.005579:0.013138:0.007257:0.004747:0.009903:0.004551:0.010357:0.004188
Eye Hospital, England), the coloured population in the :@0.519043:0.346478:0.927982:0.346478:0.927982:0.330695:0.519043:0.330695:0.008104:0.008104:0.009827:0.005564:0.010326:0.009903:0.005866:0.010311:0.003024:0.005125:0.010326:0.003024:0.004188:0.005564:0.008104:0.009223:0.010175:0.003024:0.010326:0.009223:0.010357:0.005579:0.004188:0.005564:0.005125:0.009223:0.009827:0.005564:0.009782:0.009903:0.003024:0.009903:0.009192:0.004551:0.009827:0.010357:0.005564:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005564:0.003024:0.009223:0.005564:0.005125:0.009223:0.009827:0.004188
Western Cape has a high prevalence of angle-closure :@0.519043:0.361302:0.927982:0.361302:0.927982:0.345519:0.519043:0.345519:0.014514:0.009827:0.005866:0.005125:0.009827:0.004551:0.009223:0.005171:0.012292:0.010326:0.010311:0.009827:0.005171:0.009223:0.010326:0.005866:0.005186:0.010326:0.005171:0.009223:0.003024:0.010175:0.009223:0.005171:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.005171:0.009903:0.004747:0.005171:0.010326:0.009223:0.010175:0.003024:0.009827:0.005020:0.009782:0.003024:0.009903:0.005866:0.009192:0.004551:0.009827:0.004188
glaucoma  (phD  thesis 1993, UCT  –  primary  Angle  Clo-:@0.519043:0.376126:0.923794:0.376126:0.923794:0.360344:0.519043:0.360344:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.002389:0.005579:0.008950:0.009223:0.011249:0.004188:0.002389:0.005125:0.009223:0.009827:0.005866:0.003024:0.005866:0.006592:0.008376:0.008376:0.008376:0.008376:0.004188:0.006592:0.009903:0.012292:0.006441:0.004188:0.002389:0.007560:0.004188:0.002404:0.008950:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.004188:0.002389:0.011188:0.009223:0.010175:0.003024:0.009827:0.004188:0.002389:0.012292:0.003024:0.009903:0.005020
sure Glaucoma in Cape people of Mixed Ethnic Back-:@0.519043:0.390951:0.923794:0.390951:0.923794:0.375168:0.519043:0.375168:0.005866:0.009192:0.004551:0.009827:0.005458:0.013184:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005458:0.003024:0.009223:0.005458:0.012292:0.010326:0.010311:0.009827:0.005458:0.008950:0.009827:0.009903:0.010311:0.003024:0.009827:0.005458:0.009903:0.004747:0.005458:0.013894:0.003024:0.007257:0.009827:0.010357:0.005458:0.008104:0.005125:0.009223:0.009223:0.003024:0.009782:0.005458:0.008678:0.010326:0.009782:0.007590:0.005020
ground with special Emphasis on Chronic Angle-Closure :@0.519043:0.405775:0.927982:0.405775:0.927982:0.389993:0.519043:0.389993:0.010175:0.004551:0.009903:0.009192:0.009223:0.010357:0.003402:0.012564:0.003024:0.005125:0.009223:0.003417:0.007529:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003417:0.008104:0.014182:0.010311:0.009223:0.010326:0.005866:0.003024:0.005866:0.003417:0.009903:0.009223:0.003402:0.012292:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.003402:0.011188:0.009223:0.010175:0.003024:0.009827:0.005020:0.012292:0.003024:0.009903:0.005866:0.009192:0.004551:0.009827:0.004188
Glaucoma). This is traditionally seen in Asian and Indian :@0.519043:0.420600:0.927952:0.420600:0.927952:0.404817:0.519043:0.404817:0.013184:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005579:0.004188:0.004294:0.006441:0.009223:0.003024:0.005866:0.004294:0.003024:0.005866:0.004309:0.005125:0.004551:0.010326:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.003024:0.008104:0.004294:0.005866:0.009827:0.009827:0.009223:0.004294:0.003024:0.009223:0.004294:0.011188:0.005866:0.003024:0.010326:0.009223:0.004294:0.010326:0.009223:0.010357:0.004294:0.003417:0.009223:0.010357:0.003024:0.010326:0.009223:0.004188
populations.:@0.519043:0.435424:0.609439:0.435424:0.609439:0.419641:0.519043:0.419641:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
imPACt On sOCiety:@0.519047:0.469062:0.700140:0.469062:0.700140:0.448898:0.519047:0.448898:0.005174:0.016631:0.010348:0.013674:0.014413:0.007761:0.005174:0.015522:0.013674:0.005174:0.009609:0.015522:0.014413:0.005174:0.009609:0.007761:0.011457
People  with  bilateral  visual  field  loss  from  glaucoma :@0.519047:0.485669:0.927987:0.485669:0.927987:0.469887:0.519047:0.469887:0.008950:0.009827:0.009903:0.010311:0.003024:0.009827:0.004188:0.004112:0.012564:0.003024:0.005125:0.009223:0.004188:0.004112:0.010311:0.003024:0.003024:0.010326:0.005125:0.009827:0.004551:0.010326:0.003024:0.004188:0.004112:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.004188:0.004127:0.003681:0.003681:0.009827:0.003024:0.010357:0.004188:0.004112:0.003024:0.009903:0.005866:0.005866:0.004188:0.004112:0.004747:0.004551:0.009903:0.014182:0.004188:0.004097:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188
have worse self-reported visual abilities and worse per-:@0.519047:0.500494:0.923814:0.500494:0.923814:0.484711:0.519047:0.484711:0.009223:0.010326:0.008376:0.009827:0.005095:0.012564:0.009903:0.004551:0.005866:0.009827:0.005095:0.005866:0.009827:0.003024:0.004747:0.005020:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.009827:0.010357:0.005080:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.005110:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.003024:0.009827:0.005866:0.005110:0.010326:0.009223:0.010357:0.005095:0.012564:0.009903:0.004551:0.005866:0.009827:0.005095:0.010311:0.009827:0.004551:0.005020
formance of tasks. Lighting was highlighted as the most :@0.519047:0.515318:0.928002:0.515318:0.928002:0.499535:0.519047:0.499535:0.004747:0.009903:0.004551:0.014182:0.010326:0.009223:0.009782:0.009827:0.004369:0.009903:0.004747:0.004385:0.005125:0.010326:0.005866:0.007590:0.005866:0.004188:0.004385:0.006985:0.003024:0.010175:0.009223:0.005125:0.003024:0.009223:0.010175:0.004385:0.012564:0.010326:0.005866:0.004385:0.009223:0.003024:0.010175:0.009223:0.003024:0.003024:0.010175:0.009223:0.005125:0.009827:0.010357:0.004385:0.010326:0.005866:0.004385:0.005125:0.009223:0.009827:0.004385:0.014182:0.009903:0.005866:0.005125:0.004188
common complaint when a person has glaucomatous :@0.519047:0.530142:0.928002:0.530142:0.928002:0.514360:0.519047:0.514360:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004899:0.009782:0.009903:0.014182:0.010311:0.003024:0.010326:0.003024:0.009223:0.005125:0.004914:0.012564:0.009223:0.009827:0.009223:0.004899:0.010326:0.004914:0.010311:0.009827:0.004551:0.005866:0.009903:0.009223:0.004899:0.009223:0.010326:0.005866:0.004914:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.005125:0.009903:0.009192:0.005866:0.004188
damage, followed by walking and balance. The loss of :@0.519047:0.544967:0.927972:0.544967:0.927972:0.529184:0.519047:0.529184:0.010357:0.010326:0.014182:0.010326:0.010175:0.009827:0.004188:0.004490:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.009827:0.010357:0.004490:0.010311:0.008104:0.004505:0.012564:0.010326:0.003024:0.007590:0.003024:0.009223:0.010175:0.004490:0.010326:0.009223:0.010357:0.004490:0.010311:0.010326:0.003024:0.010326:0.009223:0.009782:0.009827:0.004188:0.004490:0.006441:0.009223:0.009827:0.004490:0.003024:0.009903:0.005866:0.005866:0.004505:0.009903:0.004747:0.004188
confidence while walking leads to a decrease in overall :@0.519047:0.559791:0.928002:0.559791:0.928002:0.544008:0.519047:0.544008:0.009782:0.009903:0.009223:0.003681:0.003681:0.010357:0.009827:0.009223:0.009782:0.009827:0.003674:0.012564:0.009223:0.003024:0.003024:0.009827:0.003689:0.012564:0.010326:0.003024:0.007590:0.003024:0.009223:0.010175:0.003689:0.003024:0.009827:0.010326:0.010357:0.005866:0.003689:0.005125:0.009903:0.003689:0.010326:0.003689:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.003689:0.003024:0.009223:0.003689:0.009903:0.008376:0.009827:0.004551:0.010326:0.003024:0.003024:0.004188
quality of life and an increase in morbidity and mortality. :@0.519047:0.574615:0.928002:0.574615:0.928002:0.558833:0.519047:0.558833:0.010311:0.009192:0.010326:0.003024:0.003024:0.005125:0.008104:0.003372:0.009903:0.004747:0.003356:0.003024:0.003024:0.004747:0.009827:0.003356:0.010326:0.009223:0.010357:0.003356:0.010326:0.009223:0.003356:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.003356:0.003024:0.009223:0.003356:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.008104:0.003356:0.010326:0.009223:0.010357:0.003356:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.004188
Difficulty with reading and near-vision tasks, as well as :@0.519047:0.589440:0.927972:0.589440:0.927972:0.573657:0.519047:0.573657:0.011249:0.003024:0.004747:0.003681:0.003681:0.009782:0.009192:0.003024:0.005125:0.008104:0.005957:0.012564:0.003024:0.005125:0.009223:0.005957:0.004551:0.009827:0.010326:0.010357:0.003024:0.009223:0.010175:0.005957:0.010326:0.009223:0.010357:0.005957:0.009223:0.009827:0.010326:0.004551:0.005020:0.008376:0.003024:0.005866:0.003024:0.009903:0.009223:0.005957:0.005125:0.010326:0.005866:0.007590:0.005866:0.004188:0.005957:0.010326:0.005866:0.005957:0.012564:0.009827:0.003024:0.003024:0.005957:0.010326:0.005866:0.004188
with driving, were frequent complaints. These patients :@0.519047:0.604264:0.927987:0.604264:0.927987:0.588481:0.519047:0.588481:0.012564:0.003024:0.005125:0.009223:0.006229:0.010357:0.004551:0.003024:0.008376:0.003024:0.009223:0.010175:0.004188:0.006229:0.012564:0.009827:0.004551:0.009827:0.006229:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.006214:0.009782:0.009903:0.014182:0.010311:0.003024:0.010326:0.003024:0.009223:0.005125:0.005866:0.004188:0.006229:0.006441:0.009223:0.009827:0.005866:0.009827:0.006229:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188
also reported  an  increased  incidence  of  anxiety and :@0.519047:0.619088:0.927987:0.619088:0.927987:0.603306:0.519047:0.603306:0.010326:0.003024:0.005866:0.009903:0.006773:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.009827:0.010357:0.004188:0.002570:0.010326:0.009223:0.004188:0.002570:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004188:0.002570:0.003024:0.009223:0.009782:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004188:0.002570:0.009903:0.004747:0.004188:0.002570:0.010326:0.009223:0.007257:0.003024:0.009827:0.005125:0.008104:0.006773:0.010326:0.009223:0.010357:0.004188
worry about blindness.  These complaints can be divid-:@0.519047:0.633913:0.923808:0.633957:0.923808:0.618175:0.519047:0.618130:0.012564:0.009903:0.004551:0.004551:0.008104:0.004687:0.010326:0.010311:0.009903:0.009192:0.005125:0.004687:0.010311:0.003024:0.003024:0.009223:0.010357:0.009223:0.009827:0.005866:0.005866:0.004188:0.004877:0.004702:0.006441:0.009223:0.009827:0.005866:0.009827:0.004687:0.009782:0.009903:0.014182:0.010311:0.003024:0.010326:0.003024:0.009223:0.005125:0.005866:0.004702:0.009782:0.010326:0.009223:0.004702:0.010311:0.009827:0.004702:0.010357:0.003024:0.008376:0.003024:0.010357:-0.418779
5:@0.683877:0.628659:0.688735:0.628659:0.688735:0.619505:0.683877:0.619505:0.004858
ed into five factors.:@0.519041:0.648782:0.659119:0.648782:0.659119:0.632999:0.519041:0.632999:0.009827:0.010357:0.004188:0.003024:0.009223:0.005125:0.009903:0.004188:0.003681:0.003681:0.008376:0.009827:0.004188:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188
1. Near vision:@0.533328:0.663606:0.629576:0.663606:0.629576:0.647824:0.533328:0.647824:0.008376:0.004188:0.004188:0.011188:0.009827:0.010326:0.004551:0.004188:0.008376:0.003024:0.005866:0.003024:0.009903:0.009223
2. peripheral vision:@0.533328:0.678431:0.667298:0.678431:0.667298:0.662648:0.533328:0.662648:0.008376:0.004188:0.004188:0.008950:0.009827:0.004551:0.003024:0.010311:0.009223:0.009827:0.004551:0.010326:0.003024:0.004188:0.008376:0.003024:0.005866:0.003024:0.009903:0.009223
3. Dark adaptation and glare :@0.533328:0.693255:0.752403:0.693255:0.752403:0.677472:0.533328:0.677472:0.008376:0.004188:0.004188:0.011249:0.010326:0.004551:0.007590:0.004188:0.010326:0.010357:0.010326:0.010311:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.010326:0.009223:0.010357:0.004188:0.010175:0.003024:0.010326:0.004551:0.009827:0.004188
4. personal care and household tasks:@0.533328:0.708079:0.804186:0.708079:0.804186:0.692297:0.533328:0.692297:0.008376:0.004188:0.004188:0.008950:0.009827:0.004551:0.005866:0.009903:0.009223:0.010326:0.003024:0.004188:0.009782:0.010326:0.004551:0.009827:0.004188:0.010326:0.009223:0.010357:0.004188:0.009223:0.009903:0.009192:0.005866:0.009827:0.009223:0.009903:0.003024:0.010357:0.004188:0.005125:0.010326:0.005866:0.007590:0.005866
5. Outdoor mobility:@0.533328:0.722904:0.673134:0.722904:0.673134:0.707121:0.533328:0.707121:0.008376:0.004188:0.004188:0.013138:0.009192:0.005125:0.010357:0.009903:0.009903:0.004551:0.004188:0.014182:0.009903:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104
The  above  five  factors  correlated  well  to  the  loss  of :@0.533328:0.737728:0.927950:0.737728:0.927950:0.721945:0.533328:0.721945:0.006290:0.009071:0.009676:0.004188:0.002752:0.010175:0.010160:0.009752:0.008225:0.009676:0.004188:0.002752:0.003606:0.003606:0.008225:0.009676:0.004188:0.002752:0.004596:0.010175:0.009631:0.004974:0.009752:0.004400:0.005715:0.004188:0.002752:0.009631:0.009752:0.004400:0.004400:0.009676:0.002873:0.010175:0.004974:0.009676:0.010205:0.004188:0.002752:0.012413:0.009676:0.002873:0.002873:0.004188:0.002752:0.004974:0.009752:0.004188:0.002752:0.004974:0.009071:0.009676:0.004188:0.002752:0.002873:0.009752:0.005715:0.005715:0.004188:0.002752:0.009752:0.004747:0.004188
visual  field,  as  well  as  mean  deviation  measures  on  a :@0.519041:0.752552:0.927920:0.752552:0.927920:0.736770:0.519041:0.736770:0.008225:0.002873:0.005715:0.009041:0.010175:0.002873:0.004188:0.002903:0.003606:0.003606:0.009676:0.002873:0.010205:0.004037:0.004188:0.002903:0.010175:0.005715:0.004188:0.002903:0.012413:0.009676:0.002873:0.002873:0.004188:0.002903:0.010175:0.005715:0.004188:0.002903:0.014030:0.009676:0.010175:0.009071:0.004188:0.002903:0.010205:0.009676:0.008225:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.004188:0.002903:0.014030:0.009676:0.010175:0.005715:0.009041:0.004400:0.009676:0.005715:0.004188:0.002903:0.009752:0.009071:0.004188:0.002903:0.010326:0.004188
Humphreys visual field test. These were used in the devel:@0.519041:0.767377:0.918955:0.767377:0.918955:0.751594:0.519041:0.751594:0.010175:0.009041:0.014030:0.010160:0.009071:0.004400:0.009676:0.007953:0.005715:0.003750:0.008225:0.002873:0.005715:0.009041:0.010175:0.002873:0.003750:0.003606:0.003606:0.009676:0.002873:0.010205:0.003750:0.004974:0.009676:0.005715:0.004974:0.004037:0.003750:0.006290:0.009071:0.009676:0.005715:0.009676:0.003750:0.012413:0.009676:0.004400:0.009676:0.003750:0.009041:0.005715:0.009676:0.010205:0.003750:0.002873:0.009071:0.003750:0.004974:0.009071:0.009676:0.003750:0.010205:0.009676:0.008225:0.009676:0.003024
-:@0.918803:0.767377:0.923823:0.767377:0.923823:0.751594:0.918803:0.751594:0.005020
opment of a Glaucoma Quality of Life 15 question ques-:@0.519041:0.782201:0.923778:0.782201:0.923778:0.766418:0.519041:0.766418:0.009752:0.010160:0.014030:0.009676:0.009071:0.004974:0.004143:0.009752:0.004596:0.004143:0.010175:0.004143:0.013033:0.002873:0.010175:0.009041:0.009631:0.009752:0.014030:0.010175:0.004143:0.013017:0.009041:0.010175:0.002873:0.002873:0.004974:0.007953:0.004143:0.009752:0.004596:0.004143:0.006834:0.002873:0.004596:0.009676:0.004143:0.008225:0.008225:0.004143:0.010160:0.009041:0.009676:0.005715:0.004974:0.002873:0.009752:0.009071:0.004143:0.010160:0.009041:0.009676:0.005715:0.005020
tionnaire.:@0.519041:0.797025:0.586094:0.797025:0.586094:0.781243:0.519041:0.781243:0.004974:0.002873:0.009752:0.009071:0.009071:0.010175:0.002873:0.004400:0.009676:0.004188
6:@0.585940:0.791776:0.590798:0.791776:0.590798:0.782622:0.585940:0.782622:0.004858
 The aim of developing a glaucoma specific :@0.590712:0.797074:0.928003:0.797074:0.928003:0.781292:0.590712:0.781292:0.006169:0.006290:0.009071:0.009676:0.006169:0.010175:0.002873:0.014030:0.006169:0.009752:0.004596:0.006169:0.010205:0.009676:0.008225:0.009676:0.002873:0.009752:0.010160:0.002873:0.009071:0.010024:0.006169:0.010175:0.006169:0.010024:0.002873:0.010175:0.009041:0.009631:0.009752:0.014030:0.010175:0.006169:0.005715:0.010160:0.009676:0.009631:0.002873:0.003606:0.003606:0.009782:0.004188
quality-of-life evaluation questionnaire is to determine :@0.519048:0.811899:0.928018:0.811899:0.928018:0.796116:0.519048:0.796116:0.010160:0.009041:0.010175:0.002873:0.002873:0.004974:0.007953:0.004868:0.009752:0.004596:0.004868:0.002873:0.002873:0.004596:0.009676:0.008058:0.009676:0.008225:0.010175:0.002873:0.009041:0.010175:0.004974:0.002873:0.009752:0.009071:0.008058:0.010160:0.009041:0.009676:0.005715:0.004974:0.002873:0.009752:0.009071:0.009071:0.010175:0.002873:0.004400:0.009676:0.008058:0.002873:0.005715:0.008058:0.004974:0.009752:0.008058:0.010205:0.009676:0.004974:0.009676:0.004400:0.014030:0.002873:0.009071:0.009827:0.004188
the key measure of success with adequate treatment.:@0.519048:0.826723:0.907834:0.826723:0.907834:0.810940:0.519048:0.810940:0.004974:0.009071:0.009676:0.004037:0.007439:0.009676:0.007953:0.004037:0.014030:0.009676:0.010175:0.005715:0.009041:0.004400:0.009676:0.004037:0.009752:0.004596:0.004037:0.005715:0.009041:0.009631:0.009631:0.009676:0.005715:0.005715:0.004037:0.012413:0.002873:0.004974:0.009071:0.004037:0.010175:0.010205:0.009676:0.010160:0.009041:0.010175:0.004974:0.009676:0.004037:0.004974:0.004400:0.009676:0.010175:0.004974:0.014030:0.009676:0.009071:0.004974:0.004188
 In resource-poor settings, another individual will often :@0.533335:0.841547:0.928018:0.841547:0.928018:0.825765:0.533335:0.825765:0.003961:0.003417:0.009223:0.003961:0.004551:0.009827:0.005866:0.009903:0.009192:0.004551:0.009782:0.009827:0.005020:0.010311:0.009888:0.009903:0.004551:0.003946:0.005866:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.005866:0.004188:0.003946:0.010326:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.003946:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.003976:0.012564:0.003024:0.003024:0.003024:0.003961:0.009903:0.004747:0.005125:0.009827:0.009223:0.004188
have to look after the blind relative and therefore can-:@0.519048:0.856372:0.923830:0.856372:0.923830:0.840589:0.519048:0.840589:0.009223:0.010326:0.008376:0.009827:0.004551:0.005125:0.009903:0.004551:0.003024:0.009903:0.009903:0.007590:0.004551:0.010326:0.004747:0.005125:0.009827:0.004551:0.004551:0.005125:0.009223:0.009827:0.004551:0.010311:0.003024:0.003024:0.009223:0.010357:0.004566:0.004551:0.009827:0.003024:0.010326:0.005125:0.003024:0.008376:0.009827:0.004566:0.010326:0.009223:0.010357:0.004551:0.005125:0.009223:0.009827:0.004551:0.009827:0.004747:0.009903:0.004551:0.009827:0.004536:0.009782:0.010326:0.009223:0.005020
not be economically active or receive an education. :@0.519048:0.871196:0.927988:0.871196:0.927988:0.855414:0.519048:0.855414:0.009223:0.009903:0.005125:0.006229:0.010311:0.009827:0.006244:0.009827:0.009782:0.009903:0.009223:0.009903:0.014167:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.006244:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.006244:0.009903:0.004551:0.006229:0.004551:0.009827:0.009782:0.009827:0.003024:0.008376:0.009827:0.006229:0.010326:0.009223:0.006229:0.009827:0.010357:0.009192:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188
This has a knock-on effect in terms of access to health-:@0.519048:0.886021:0.923785:0.886021:0.923785:0.870238:0.519048:0.870238:0.006441:0.009223:0.003024:0.005866:0.004747:0.009223:0.010326:0.005866:0.004747:0.010326:0.004747:0.007590:0.009223:0.009903:0.009782:0.007590:0.005020:0.009903:0.009223:0.004732:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004747:0.003024:0.009223:0.004747:0.005125:0.009827:0.004551:0.014182:0.005866:0.004747:0.009903:0.004747:0.004747:0.010326:0.009782:0.009782:0.009827:0.005866:0.005866:0.004747:0.005125:0.009903:0.004747:0.009223:0.009827:0.010326:0.003024:0.005125:0.009223:0.005020
care and treatment compliance, with less than optimal :@0.519048:0.900845:0.927988:0.900845:0.927988:0.885062:0.519048:0.885062:0.009782:0.010326:0.004551:0.009827:0.004158:0.010326:0.009223:0.010357:0.004173:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004158:0.009782:0.009903:0.014182:0.010311:0.003024:0.003024:0.010326:0.009223:0.009782:0.009827:0.004188:0.004173:0.012564:0.003024:0.005125:0.009223:0.004173:0.003024:0.009827:0.005866:0.005866:0.004173:0.005125:0.009223:0.010326:0.009223:0.004158:0.009903:0.010311:0.005125:0.003024:0.014182:0.010326:0.003024:0.004188
diagnosis and management. Owing to poor awareness :@0.519048:0.915669:0.927988:0.915669:0.927988:0.899887:0.519048:0.899887:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004052:0.010326:0.009223:0.010357:0.004052:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.004037:0.013138:0.012564:0.003024:0.009223:0.010175:0.004052:0.005125:0.009903:0.004052:0.010311:0.009903:0.009903:0.004551:0.004037:0.010326:0.012564:0.010326:0.004551:0.009827:0.009223:0.009827:0.005866:0.005866:0.004188
and socio-economic  hardships, patients present  late :@0.519048:0.930494:0.928003:0.930494:0.928003:0.914711:0.519048:0.914711:0.010326:0.009223:0.010357:0.008195:0.005866:0.009903:0.009782:0.003024:0.009903:0.005020:0.009827:0.009782:0.009903:0.009223:0.009903:0.014182:0.003024:0.009782:0.004188:0.003991:0.009223:0.010326:0.004551:0.010357:0.005866:0.009223:0.003024:0.010311:0.005866:0.004188:0.008195:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.008195:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.004188:0.003991:0.003024:0.010326:0.005125:0.009827:0.004188
and have poor outcomes.:@0.519048:0.945318:0.711906:0.945318:0.711906:0.929535:0.519048:0.929535:0.010326:0.009223:0.010357:0.004188:0.009223:0.010326:0.008376:0.009827:0.004188:0.010311:0.009903:0.009903:0.004551:0.004188:0.009903:0.009192:0.005125:0.009782:0.009903:0.014182:0.009827:0.005866:0.004188
4:@0.711882:0.940064:0.716740:0.940064:0.716740:0.930910:0.711882:0.930910:0.004858